Panlilio Alfredo Santos
CIK: 0002118623
Associated companies
Transaction History
| PHI | ▼ Sell | Open Market | 465 | $11K | 4/10/2026 | View on chart |
| PHI | ▼ Sell | Open Market | 210 | $5K | 4/10/2026 | View on chart |
| PHI | ▼ Sell | Open Market | 205 | $5K | 4/10/2026 | View on chart |
| PHI | ▼ Sell | Open Market | 590 | $13K | 4/10/2026 | View on chart |
| PHI | ▼ Sell | Open Market | 3,035 | $69K | 4/10/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 24, 2026
PHI Receives New Analyst Coverage with $26.42 Target
PHI has recently attracted new analyst coverage, with a target price of $26.42. The coverage highlights the company's solid dividend yield of 7.46% and its valuation at a trailing P/E of 8.7. The stock is currently trading near its support level of $19.31, which has been tested multiple times.
PHI Receives New Analyst Coverage with $26.42 Target. PHI has recently attracted new analyst coverage, with a target price of $26.42. The coverage highlights the company's solid dividend yield of 7.46% and its valuation at a trailing P/E of 8.7. The stock is currently trading near its support level of $19.31, which has been tested multiple times.